Johnson & Johnson pauses coronavirus vaccine trial following ‘unexplained illness’ in participant
Pharmaceutical giant Johnson & Johnson on Monday night announced that it had paused its late-stage COVID-19 vaccine trial after an “unexplained illness” was reported in a participant.